Transcatheter aortic valve replacement and cardiac conduction

References

• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607.
   PubMed Web of Science ®Google Scholar
• Smith C, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
   PubMed Web of Science ®Google Scholar
• Chakos A, Wilson-Smith A, Arora S, et al. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017;5:432–443.
   Google Scholar
• Kawashima T, Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol. 2014;174:1–6.
   PubMed Web of Science ®Google Scholar
• Massing GK, James TN. Anatomical configuration of the His bundle and bundle branches in the human heart. Circulation. 1976;4:609–621.
   Google Scholar
• Mori S, Tretter JT, Toba T, et al. Relationship between the membranous septum and the virtual basal rink of the aortic root in candidates for transcatheter implantation of the aortic valve. Clin Anat. 2018;4:525–534.
   Google Scholar
• Hamdan A, Guetta V, Klempfner R, et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8:1218–1228.
   PubMed Web of Science ®Google Scholar
• Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation; insights from a necropsy study. Circulation. 2009;120:e29–30.
   PubMed Web of Science ®Google Scholar
• Shreenivas, Messer AL, Johnson RP, et al. Prognosis in bundle branch block. I. Factors influencing the survival period in right bundle branch block. Am Heart J. 1950;6:891–902.
   Google Scholar
• Johnson RP, Messer AL, Shreenivas, et al. Prognosis in bundle branch block II. Factors influencing the survival period in left bundle branch block. Am Heart J. 1951;2:225–238.
   Google Scholar
• Messer AL, Johnson RP, Shreenivas, et al. Prognosis in bundle branch block. III. A comparison of right and left bundle branch block with a note on the relative incidence of each. Am Heart J. 1951;2:239–245.
   Google Scholar
• Yater WM, Cornell VH. Heart Block due to calcareous lesions of the bundle of His. Review and report of a case with detailed histopathologic study. Ann Intern Med. 1935;8:777–789.
   Google Scholar
• Warshawsky H, Abramson W. Complete heart block in calcareous aortic stenosis. Ann Intern Med. 1947;27:1040.
   PubMed Web of Science ®Google Scholar
• MacMillan RM, Demorizi NM, Gessman LJ, et al. Correlates of prolonged HV conduction in aortic stenosis. Am Heart J. 1985;119:56–60.
   Google Scholar
• Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement. J Am Coll Cardiol Intv. 2016;9:2189–2199.
   Google Scholar
• Hwang YM, Kim J, Lee JH, et al. Conduction disturbance after isolated surgical aortic valve replacement in degenerative aortic stenosis. J Thorac Cardiovasc Surg. 2017;154:1556–1565.
   PubMed Web of Science ®Google Scholar
• Bleizffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after trans-catheter aortic valve implantation. J Am Coll Cardiol Intv. 2010;3:524–530.
   Google Scholar
• Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revealing system. Circ Cardiovasc Interv. 2010;3:359–366.
   PubMed Web of Science ®Google Scholar
• Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011;123:951–960.
   PubMed Web of Science ®Google Scholar
• Bagur R, Rodes-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. J Am Coll Cardiol Intv. 2012;5:540–551.
   Google Scholar
• Chorianopoulos E, Krumsdorf U, Pleger ST, et al. Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve aortic bioprosthesis. Clin Res Cardiol. 2012;101:349–355.
   PubMed Web of Science ®Google Scholar
• De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic corevalve implantation. Am Heart J. 2012;163:492–499.
   PubMed Web of Science ®Google Scholar
• Munoz-Garcia AJ, Hernandez-Garcia JM, Jimenez-Navarro MF, et al. factors predicting and having an impact on the need for a permanent pacemaker after corevalve prosthesis implantation using the new accutrak delivery catheter system. J Am Coll Cardiol Intv. 2012;5:533–539.
   Google Scholar
• van der Boon RM, Van Mieghem NM, Theuns DA, et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding medtronic corevalve system. Int J Cardiol. 2013;168:1269–1273.
   PubMed Web of Science ®Google Scholar
• Urena M, Hayek S, Cheema AN, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement. Circulation. 2015;131:469–477.
   PubMed Web of Science ®Google Scholar
• Mehaffey JH, Haywood NS, Hawkins RB, et al. Need for permanent pacemaker after surgical aortic valve replacement reduces long-term survival. Ann Thorac Surg 2018;106:460-465.
   Web of Science ®Google Scholar
• Greason KL, Lahr BD, Stulak JM, et al. Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement. Ann Thorac Surg. 2017;104:1259–1264.
   PubMed Web of Science ®Google Scholar
• Borger MA, Moustafine V, Conradi L, et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg. 2015;99(1):17–25.
   PubMed Web of Science ®Google Scholar
• Romano MA, Koeckert M, Mutaz MA, et al. Permanent pacemaker implantation following rapid deployment aortic valve replacement. Ann Thorac Surg. 2018;106:685–690.
   Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol. 2008;51(21):e1–62.
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European society of cardiology (ESC) . developed in collaboration with the European heart rhythm association (EHRA). Eur Heart J. 2013;34(29):2281–2329.
   PubMed Web of Science ®Google Scholar
• Hermann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134:130–140, aorticstenosis. Circulation
   PubMed Web of Science ®Google Scholar
• Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–1981.
   PubMed Web of Science ®Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Reardon MJ, Khabbaz K, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery. J Am Coll Cardiol Intv. 2017;10:268–275.
   Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in Intermediate-risk patients. N Engl J Med. 2017;376:1321–1331.
   PubMed Web of Science ®Google Scholar
• Forrest JK, Mangi AA, Popma JJ, et al. Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap. J Am Coll Cardiol Intv. 2018;11:160–168.
   Google Scholar
• Meredith IT, Dumonteil N, Blackman DJ, et al. Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients. EuroIntervention. 2017;13:788–795.
   PubMed Web of Science ®Google Scholar
• Feldman TE, Reardon MJ, Rajagopal V, et al. Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high risk patients with aortic stenosis: the Reprise III randomized clinical trial. JAMA. 2018;319:27–37.
   PubMed Web of Science ®Google Scholar
• Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR. J Am Coll Cardiol. 2014;64:129–140.
   PubMed Web of Science ®Google Scholar
• Chamandi C, Barbanti M, Munoz-Garcia A, et al. Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement. J Am Coll Cardiol Intv. 2018;11:301–310.
   Google Scholar
• Auffret V, Puri R, Urena M, et al. Conduction abnormalities after transcatheter aortic valve replacement. Circulation. 2017;136:1049–1069.
   PubMed Web of Science ®Google Scholar
• Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. J Am Coll Cardiol Intv. 2016;9:2200–2209.
   Google Scholar
• De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from Edwards Sapien XT to Sapien 3 transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2016;9:805–813.
   Google Scholar
• Sorajja P, Kodali S, Reardon M, et al. Outcomes for the commercial use of self-expanding prostheses in transcatheter aortic valve replacement: A report from the STS/ACC TVT registry. J Am Coll Cardiol Intv. 2017;10:2090–2098.
   Google Scholar
• Rampat R, Khawaja Z, Hillig-Smith R, et al. Conduction abnormalities and permanent pacemaker implantation after transcatheter aortic valve replacement using the repositionable LOTUS device: the United Kingdom experience. J Am Coll Cardiol Intv. 2017;10:1247–1253.
   Google Scholar
• Kempfert J, Holzhey D, Hofmann S, et al. First registry results fom the newly approved ACURATE TA TAVI system. Eur J Cardiothorac Surg. 2015;48:137–141.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Ko YG, Han S, et al. Predictors of permanent pacemaker insertion following transcatheter aortic valve replacement with the CoreValve revalving system based on computed tomography analysis: an Asian multicenter registry study. J Invasive Cardiol. 2015;27:334–340.
   PubMed Web of Science ®Google Scholar
• Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. J Am Coll Cardiol Img. 2017;10:1139–1147.
   Google Scholar
• Mouillet G, Lellouche N, Lim P, et al. Patients without prolonger QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv. 2013;81:882–887.
   PubMed Web of Science ®Google Scholar
• Rivard L, Schram G, Asgar A, et al. Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement. Heart Rhythm. 2015;12:321–329.
   PubMed Web of Science ®Google Scholar
• Naveh S, Perlman GY, Elitsur Y, et al. Electrocardiographic predictors of long-term cardiac pacing dependency following transcatheter aortic valve implantation. J Cardiovasc Electrophysiol. 2017;28:216–223.
   PubMed Web of Science ®Google Scholar
• Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement, the PARTNER trial and registry. J Am Coll Cardiol Intv. 2015;8:60–69.
   Google Scholar
• Kereiakes DJ, Meduri CU, Makkar RR, et al. Pacemaker dependency following transcatheter aortic valve implantation: A subanalysis of the REPRISE III randomized controlled clinical trial. Presented at the American College of Cardiology Scientific Sessions, 2018 March 10; Orlando, FL.
   Google Scholar
• van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI – frequency and causes. Nat Rev Cardiol. 2012;9:454–463.
   PubMed Web of Science ®Google Scholar
• Regueiro A, Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement – A systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9:e003635.
   PubMed Web of Science ®Google Scholar
• Nazif T, George I, Dizon J, et al. Clinical impact of new left bundle branch block in intermediate risk patients undergoing TAVR: an analysis of the PARTNER II trial and registries. J Am Coll Cardiol. 2018;71(11_S):955. Presented at the American College of Cardiology Scientific Sessions, March 10th, 2018; Orlando, FL.
   Web of Science ®Google Scholar
• Nielsen JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol. 2003;42:614–623.
   PubMed Web of Science ®Google Scholar
• Steinberg JS, Fischer A, Wang P, et al. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol. 2005; 16:359–65.
   PubMed Web of Science ®Google Scholar
• Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107:2932–2937.
   PubMed Web of Science ®Google Scholar
• Aljabbary T, Qui F, Masih S, et al. Association of clinical and economic outcomes with permanent pacemaker implantation after transcatheter aortic valve replacement. JAMA Network Open. 2018;1:e180088.
   PubMed Web of Science ®Google Scholar
• Jørgensen TH, De Backer O, Gerds TA, et al. Immediate post-procedural 12-lead electrocardiography as predictor of late conduction defects after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:1509–1518.
   PubMedGoogle Scholar